ArticleDiabetologia2020

Evaluating the impact of AMPK activation, a target of metformin, on risk of cardiovascular diseases and cancer in the UK Biobank: a Mendelian randomisation study.

Shan Luo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.